KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio (2018 - 2025)

TherapeuticsMD's Interest Coverage Ratio history spans 12 years, with the latest figure at 287.33 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 23.99% year-over-year to 287.33; the TTM value through Dec 2025 reached 568.57, up 20.44%, while the annual FY2021 figure was 3.53, 35.21% up from the prior year.
  • Interest Coverage Ratio reached 287.33 in Q3 2025 per TXMD's latest filing, up from 347.5 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 12.76 in Q4 2021 to a low of 557.8 in Q2 2024.
  • Average Interest Coverage Ratio over 5 years is 169.85, with a median of 54.93 recorded in 2023.
  • Peak YoY movement for Interest Coverage Ratio: surged 441.4% in 2021, then crashed 1500.65% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 12.76 in 2021, then tumbled by 126.11% to 3.33 in 2022, then tumbled by 2560.24% to 88.65 in 2023, then tumbled by 326.4% to 378.0 in 2024, then rose by 23.99% to 287.33 in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Interest Coverage Ratio are 287.33 (Q3 2025), 347.5 (Q2 2025), and 435.5 (Q1 2025).